A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Essen Biotech
University of California, Davis
AgonOx, Inc.
Hadassah Medical Organization
Vall d'Hebron Institute of Oncology
National Cancer Institute (NCI)
Fate Therapeutics
BGI, China
Genocea Biosciences, Inc.